2019
DOI: 10.2147/lra.s197386
|View full text |Cite
|
Sign up to set email alerts
|

<p>Comparison of subcutaneous dexmedetomidine versus clonidine as an adjuvant to spinal anestheia: a randomized double blind control trial</p>

Abstract: Background: Alpha-2 adrenergic agonists like clonidine and dexmedetomidine prolong the duration of postoperative analgesia and improve the quality of subarachnoid block (SAB) when used as adjuvant in various routes. However, addition of these drugs by IV or intrathecal routes are known to cause hemodynamic instability. The subcutaneous (SC) route provides similar efficacy as IV administration with less hemodynamic instability and prolonged effect. Aims : To compare the effica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 12 publications
0
5
0
Order By: Relevance
“…Several studies had a similar result. 40,41 Gautam et al 42 suggested that dexmedetomidine is better than fentanyl as an intrathecal adjuvant to reduce visceral pain and in prolonged post-operative analgesia. Some studies considered that dexmedetomidine induces vasoconstriction by acting on the a2-adrenergic receptor to help prolong the period of analgesia, 43,44 while Yoshitomi et al 45 suggested that dexmedetomidine directly affects its ability via the a2-adrenergic receptor.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Several studies had a similar result. 40,41 Gautam et al 42 suggested that dexmedetomidine is better than fentanyl as an intrathecal adjuvant to reduce visceral pain and in prolonged post-operative analgesia. Some studies considered that dexmedetomidine induces vasoconstriction by acting on the a2-adrenergic receptor to help prolong the period of analgesia, 43,44 while Yoshitomi et al 45 suggested that dexmedetomidine directly affects its ability via the a2-adrenergic receptor.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies had a similar result. 40,41 Gautam et al. 42 suggested that dexmedetomidine is better than fentanyl as an intrathecal adjuvant to reduce visceral pain and in prolonged post-operative analgesia.…”
Section: Discussionmentioning
confidence: 99%
“…subcutaneous clonidine and dexmedetomidine prolonged the duration of post-operative analgesia and reduced analgesic requirements when used as adjuvants to subarachnoid block (SAB). 47 There is a case report that shows both the SC and TD routes are safe and viable options for treating dystonia pain with clonidine in the palliative setting. 48 A retrospective study review examined the SC route of administration in 113 patients (79/113 cancer) suffering from opioid poorly responsive pain (39), agitation or both ( 35) 8 (see Table 1).…”
Section: Subcutaneous Clonidinementioning
confidence: 99%
“…In these tests, clonidine given subcutaneously was six to seven times more potent than morphine 46 . A study from Divya B showed that both subcutaneous clonidine and dexmedetomidine prolonged the duration of post‐operative analgesia and reduced analgesic requirements when used as adjuvants to subarachnoid block (SAB) 47 . There is a case report that shows both the SC and TD routes are safe and viable options for treating dystonia pain with clonidine in the palliative setting 48 .…”
Section: Clinical Pharmacodynamicsmentioning
confidence: 99%
“…It has been shown that clonidine and dexmedetomidine administered orally, intramuscularly, and intravenously also prolong the anesthetic effect of intrathecal LA [35][36][37][38][39][40].…”
Section: Dexmedetomidinementioning
confidence: 99%